Veraxa Biotech AG

Veraxa Biotech AG financial statements

Veraxa Biotech AG's income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.

FY2025

RevenueCHF 23.43KEODHD
Net income−CHF 66.61MEODHD
Cash and equivalentsCHF 1.61MEODHD

Veraxa Biotech AG financials on 6ix · Veraxa Biotech AG on 6ix